CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1 Dose ...

Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found ...

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...

Biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP) isn't a name on many investors' radar -- and understandably so. Its ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

A team from UC San Diego, John Hopkins and UC Berkeley Universities found a way to edit a single gene in a mosquito that ...

CRISPR research is advancing at a rapid pace, and it can be hard to keep up. In only seven years, CRISPR went from an evolutionary adaptation in bacteria to a gene-editing tool that created the ...

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology. By Rebecca Sohn Updated Jul 28, 2021 5:01 PM EDT Get the Popular Science ...

Trained in the labs of Crispr inventors and pioneers, Janice Chen, Nicole Gaudelli, Omar Abudayyeh and Jonathan Gootenberg discuss the gene-editing trials they are working on, with the goal of ...